Exchange Traded Concepts, LLC Innoviva, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $7.62 Billion
  • Q2 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 180,982 shares of INVA stock, worth $3.47 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
180,982
Previous 176,025 2.82%
Holding current value
$3.47 Million
Previous $3.19 Million 13.91%
% of portfolio
0.05%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 10, 2025
BUY
$17.1 - $21.8 $84,764 - $108,062
4,957 Added 2.82%
180,982 $3.64 Million
Q1 2025

Apr 17, 2025
BUY
$17.21 - $18.98 $241,284 - $266,099
14,020 Added 8.65%
176,025 $3.19 Million
Q4 2024

Jan 21, 2025
BUY
$17.35 - $20.32 $125,267 - $146,710
7,220 Added 4.66%
162,005 $2.81 Million
Q3 2024

Oct 10, 2024
SELL
$16.33 - $20.04 $453,222 - $556,190
-27,754 Reduced 15.2%
154,785 $2.99 Million
Q2 2024

Aug 13, 2024
BUY
$14.4 - $16.4 $98,726 - $112,438
6,856 Added 3.9%
182,539 $2.99 Million
Q1 2024

Apr 15, 2024
BUY
$14.56 - $16.78 $248,932 - $286,887
17,097 Added 10.78%
175,683 $2.68 Million
Q4 2023

Jan 05, 2024
BUY
$12.32 - $16.27 $20,056 - $26,487
1,628 Added 1.04%
158,586 $2.54 Million
Q3 2023

Oct 18, 2023
SELL
$12.37 - $13.89 $234,164 - $262,937
-18,930 Reduced 10.76%
156,958 $2.04 Million
Q2 2023

Jul 20, 2023
SELL
$11.39 - $13.72 $18,793 - $22,638
-1,650 Reduced 0.93%
175,888 $2.24 Million
Q1 2023

Apr 12, 2023
BUY
$10.73 - $13.6 $285,696 - $362,113
26,626 Added 17.64%
177,538 $2 Million
Q4 2022

Jan 17, 2023
SELL
$11.8 - $13.78 $319,721 - $373,369
-27,095 Reduced 15.22%
150,912 $2 Million
Q3 2022

Oct 07, 2022
BUY
$11.61 - $15.22 $118,677 - $155,578
10,222 Added 6.09%
178,007 $2.07 Million
Q2 2022

Jul 20, 2022
BUY
$14.32 - $19.88 $76,425 - $106,099
5,337 Added 3.29%
167,785 $2.48 Million
Q1 2022

Apr 26, 2022
BUY
$15.39 - $20.25 $1.92 Million - $2.52 Million
124,545 Added 328.59%
162,448 $3.14 Million
Q4 2021

Jan 13, 2022
BUY
$15.91 - $18.72 $10,930 - $12,860
687 Added 1.85%
37,903 $654,000
Q3 2021

Oct 18, 2021
SELL
$13.06 - $17.24 $105,590 - $139,385
-8,085 Reduced 17.85%
37,216 $622,000
Q2 2021

Jul 30, 2021
BUY
$11.45 - $13.96 $53,986 - $65,821
4,715 Added 11.62%
45,301 $607,000
Q1 2021

Apr 20, 2021
BUY
$11.06 - $12.87 $201,745 - $234,761
18,241 Added 81.63%
40,586 $485,000
Q4 2020

Jan 19, 2021
BUY
$9.33 - $12.48 $31,759 - $42,481
3,404 Added 17.97%
22,345 $277,000
Q3 2020

Oct 30, 2020
BUY
$10.33 - $14.49 $195,660 - $274,455
18,941 New
18,941 $198,000

Others Institutions Holding INVA

# of Institutions
256
Shares Held
75.1M
Call Options Held
2.3K
Put Options Held
2.4K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.34B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email